During this fireside chat, we welcome MannKind, ticker symbol of MNKD on the NASDAQ, and their Chief Executive Officer, Mike Castagna. MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.

This Fireside Chat was recorded during the Lytham Partners Spring 2023 Investor Conference.